Ebrahimi, Elmira, and Reza Shirkoohi. 2018. “What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?”. Archives of Breast Cancer, November, 148-49. https://doi.org/10.32768/abc.201854148-149.